Evidence map›Paper›PMID 19915456›Full record

ReviewCurrent opinion in allergy and clinical immunology2010

An update on the role of leukotrienes in asthma.

Teal S Hallstrand, William R Henderson

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 164 citations in OpenAlex.

  1. Autocrine CysLTOncogene · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The Association between Dyslipidemia and Pulmonary Diseases.Journal of atherosclerosis and thrombosis · 2024
    Review
  7. Lipids in Equine Airway Inflammation: An Overview of Current Knowledge.Animals : an open access journal from MDPI · 2024
    Review
  8. Testosterone Enhances KInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Hematopoietic 12/15-lipoxygenase activity negatively contributes to fungal-associated allergic asthma.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  11. Review
  12. Eosinophils: A Friend or Foe in Human Health and Diseases.Kidney diseases (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Review
  15. Leukotriene BHeliyon · 2021
    Article
  16. Review
  17. Integrated associations of nasopharyngeal and serum metabolome with bronchiolitis severity and asthma: A multicenter prospective cohort study.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021
    Article
  18. Review
  19. Article
  20. Sex Hormones and Lung Inflammation.Advances in experimental medicine and biology · 2021
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Teal S HallstrandUniversity of Washington, Seattle, USA.
William R Henderson
ENT and Allergy · USUniversity of Washington · US

Funding

Secretory Phospholipase A2s in Airway PathophysiologyR01HL089215 · NHLBI · UNIVERSITY OF WASHINGTON · PI HALLSTRAND, TEAL S · 2008 to 2017
$4.0M
5-LIPOXYGENASE PRODUCTS IN ASTHMATIC IMMUNE RESPONSER01AI042989 · NIAID · UNIVERSITY OF WASHINGTON · PI HENDERSON, WILLIAM REED · 1998 to 2008
$2.4M
NHLBI NIH HHS R01 HL089215NIAID NIH HHS R01 AI042989
6 · The paper itself

Abstract

purpose of reviewLeukotrienes are lipid mediators involved in the pathogenesis of asthma. There is significant new information about the actions of leukotrienes in asthma and the evolving role of antileukotriene therapies. We review recent findings on regulation of leukotriene synthesis, biological function of leukotrienes in disease models, and use of leukotriene modifiers in clinical practice. RECENT

findingsOur understanding of the regulation of leukotriene synthesis at a molecular level has greatly advanced. Recent evidence indicates that genetic variation in the leukotriene synthetic pathway affects the clinical response to leukotriene modifiers. The participation of leukotriene B4 in the allergic sensitization process in animal models suggests a larger role for leukotriene B4 in asthma. Preclinical and in-vitro models suggest that the cysteinyl leukotrienes are important in airway remodeling. Leukotrienes are key mediators of exercise-induced bronchoconstriction with recent studies demonstrating that leukotriene modifiers reduce the severity of exercise-induced bronchoconstriction during short-term and long-term use. SUMMARY: Leukotrienes are clearly involved in airway inflammation and certain clinical features of asthma. Evolving evidence indicates that leukotriene B4 has an important role in the development of asthma and that cysteinyl leukotrienes are key mediators of the airway remodeling process.

Indexed as

Airway RemodelingAnimalsAsthmaDisease ProgressionHumansLeukotriene AntagonistsLeukotrienesPolymorphism, GeneticLeukotriene AntagonistsLeukotrienes

Identifiers

PMID19915456
PMCPMC2838730
OpenAlexW2041407803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.